Mar 26 |
Here's Why We're Not Too Worried About Abeona Therapeutics' (NASDAQ:ABEO) Cash Burn Situation
|
Mar 19 |
Abeona Therapeutics Inc (ABEO) Reports Full Year 2023 Financial Results
|
Mar 18 |
Abeona Therapeutics GAAP EPS of -$2.53, revenue of $3.5M
|
Mar 18 |
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
|
Mar 10 |
Several Insiders Invested In Abeona Therapeutics Flagging Positive News
|
Feb 15 |
Steven Cohen's Firm Increases Stake in Abeona Therapeutics Inc
|
Feb 12 |
Individual investors in Abeona Therapeutics Inc. (NASDAQ:ABEO) are its biggest bettors, and their bets paid off as stock gained 45% last week
|
Feb 8 |
Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
|
Feb 7 |
Abeona Therapeutics says CEO Seshadri buys 20K shares
|
Feb 1 |
Abeona issues update on FDA market application for pz-cel
|